Jamie Dananberg
Chief Tech/Sci/R&D Officer presso ANNEXON, INC.
Patrimonio netto: 371 606 $ in data 31/03/2024
Profilo
Jamie Dananberg is currently the Chief Medical Officer at Annexon, Inc. and a Trustee at Keck Graduate Institute of Applied Life Sciences.
Previously, he worked as the VP-Translational Medicine & Tailored Therapeutics at Eli Lilly & Co. from 2000 to 2012, as the Executive Vice President at Takeda Pharmaceutical Co., Ltd.
from 2012 to 2015, and as the Chief Medical Officer at Unity Biotechnology, Inc. from 2016 to 2023.
He received his undergraduate and doctorate degrees from Tufts University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ANNEXON, INC.
0.04% | 16/02/2024 | 39 000 ( 0.04% ) | 279 630 $ | 31/03/2024 |
| 24/04/2023 | 56 083 ( 0.33% ) | 91 976 $ | 31/03/2024 |
Posizioni attive di Jamie Dananberg
| Società | Posizione | Inizio |
|---|---|---|
| ANNEXON, INC. | Chief Tech/Sci/R&D Officer | 27/07/2023 |
| Keck Graduate Institute of Applied Life Sciences | Director/Board Member | - |
Precedenti posizioni note di Jamie Dananberg
| Società | Posizione | Fine |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 30/04/2023 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/10/2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/09/2012 |
Formazione di Jamie Dananberg
| Tufts University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ANNEXON, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
- Borsa valori
- Insiders
- Jamie Dananberg
